loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Certificates of Suitability (CEPs) for cep_2009_287___rev_03 Active Pharmaceutical Ingredient (API) issued by the EDQM. Original Data: EDQM Database

    Client Virtual Booth
    Menu

    EUROAPI

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    Key Products KEY PRODUCTS

    INTERMEDIATES

    SERVICES

    Key Services KEY SERVICES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    PharmaCompass Sponsored Ads

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 FRANCOPIA Paris FR (1)

    filter

    01 Naltrexone hydrochloride (1)

    filter

    01 France (1)

    filter

    01 Valid (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    FRANCOPIA Paris FR

    Contact Supplier
    • FDA
    • EDQM
    Virtual BoothEUROAPI, the leading small molecules API player, provides both API sales & CDMO services.
    Contact Supplier Contact Supplier
    Flag France
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    Naltrexone hydrochloride

    PDF Supplier PDF
    URL Supplier Web Content
    Other DMF ROW
    CEP 2009-287 - Rev 03
    Valid
    Chemical
    2024-03-01
    1790
    EUROAPI Compnay Banner

    CPhI North America

    Booth #917

    envelop Contact Supplier

    Looking for Certificates of Suitability (CEPs) for CEP 2009-287 - Rev 03 of Francopia Paris Fr

    Looking for Certificates of Suitability (CEPs) for CEP 2009-287 - Rev 03 of Francopia Paris Fr 1

    20

    Francopia Paris Fr, based in France, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    They are recognized for EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    One of their significant offerings is Naltrexone hydrochloride, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2009-287 - Rev 03

    This Chemical Type CEP, issued on March 01, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.

    Substance Number 1790 associated with this CEP further emphasizes

    Post Enquiry
    POST ENQUIRY